Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesangial matrix modulation and glomerulosclerosis.

A B Fogo1

  • 1Department of Pathology, Vanderbilt University Medical Center, Nashville, Tenn., USA. agnes.fogo@mcmail.vanderbilt.edu

Experimental Nephrology
|April 24, 1999
PubMed
Summary

Kidney disease progression, marked by glomerulosclerosis and fibrosis, may be reversible. The renin-angiotensin system drives matrix accumulation, but understanding these mechanisms offers hope for reversing kidney damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertensive nephrosclerosis: wider kidney biopsy indications may be needed to improve diagnostics.

Journal of internal medicine·2020
Same author

Thin Glomerular Basement Membrane in a Kidney Transplant of an Alport's Syndrome Patient: A Case Report.

Transplantation proceedings·2017
Same author

Postinfectious glomerulonephritis: Is there a role for steroids?

Indian journal of nephrology·2011
Same author

Banff 07 classification of renal allograft pathology: updates and future directions.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

PPAR-gamma agonist protects podocytes from injury.

Kidney international·2007
Same author

Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency.

Kidney international·2007

Area of Science:

  • Nephrology
  • Renal Pathology
  • Molecular Biology

Background:

  • Progressive kidney disease leads to irreversible structural injuries like glomerulosclerosis and tubulointerstitial fibrosis.
  • These fibrotic processes were traditionally considered unavoidable, irrespective of the underlying renal disease.
  • Emerging evidence suggests that sclerosis in the kidneys might be a reversible condition.

Purpose of the Study:

  • To review the mechanisms of mesangial matrix accumulation in glomerulosclerosis.
  • To explore the role of the renin-angiotensin system in promoting matrix accumulation.
  • To discuss the potential reversibility of renal fibrotic processes.

Main Methods:

  • Review of existing literature on renal disease progression and matrix accumulation.
  • Analysis of the renin-angiotensin system's involvement in mesangial matrix synthesis and degradation.
  • Examination of plasminogen activator inhibitor-1's role in thrombosis and matrix degradation.

Main Results:

  • Mesangial matrix accumulation, central to glomerulosclerosis, occurs when synthesis outpaces degradation.
  • The renin-angiotensin system is a key regulator, influencing multiple pathways that enhance matrix deposition.
  • Angiotensin directly induces plasminogen activator inhibitor-1, which inhibits matrix degradation and promotes thrombosis.

Conclusions:

  • The progression of renal diseases involves structural injuries that may not be immutable.
  • The renin-angiotensin system plays a critical role in driving mesangial matrix accumulation.
  • Understanding these pathways, including plasminogen activator inhibitor-1, offers potential therapeutic targets for reversing kidney damage.

Related Experiment Videos